XML 30 R20.htm IDEA: XBRL DOCUMENT v3.20.4
14. STOCK OPTIONS
3 Months Ended
Dec. 31, 2020
Share-based Payment Arrangement [Abstract]  
14. STOCK OPTIONS

 14. STOCK OPTIONS

 

The Company sponsors a stock-based incentive compensation plan known as the 2017 Incentive Plan (the “Plan”), which was established by the Board of Directors of the Company on June 19, 2017. On October 7, 2020, the Company executed a first amendment to thePlan to increase its share pool from 300,000 to 1,500,000 shares of common stock. As of December 31, 2020, there were 553,190 shares available for issuance under the Plan.

 

The Plan allows the Company to grant incentive stock options, non-qualified stock options, stock appreciation right, or restricted stock. The incentive stock options are exercisable for up to ten years, at an option price per share not less than the fair market value on the date the option is granted. The incentive stock options are limited to persons who are regular full-time employees of the Company at the date of the grant of the option. Non-qualified options may be granted to any person, including, but not limited to, employees, independent agents, consultants and attorneys, who the Company’s Board believes have contributed, or will contribute, to the success of the Company. Non-qualified options may be issued at option prices of less than fair market value on the date of grant and may be exercisable for up to ten years from date of grant. The option vesting schedule for options granted is determined by the Board of Directors at the time of the grant. The Plan provides for accelerated vesting of unvested options if there is a change in control, as defined in the Plan.

 

The following is a summary of stock option activity during the three months ended December 31, 2020.

 

   Number of Option Shares  Weighted Average Exercise Price
Balance, September 30, 2020   277,948   $6.34
Options granted   291,500    8.68
Options expired   11,008    7.93
Options cancelled           
Options exercised   10,383      
Balance, December 31, 2020   548,057   $7.66

 

As of December 31, 2020, there are options exercisable to purchase 388,895 shares of common stock in the Company. As of December 31, 2020, the outstanding options have a weighted average remaining term of was 2.60 years and an intrinsic value of $11,800,257.

 

Option activity for the three months ended December 31, 2020

 

 

During the three months ended December 31, 2020, the Company issued 291,500 options to purchase shares of common stock to employees. The shares were granted at quoted market prices ranging from $8.07 to $12.48. The options were valued at issuance using the Black Scholes model and stock compensation expense of $385,883 was recorded as a result of the issuances, with the balance of $953,126 offset against bonuses accrued in the prior year

 

 

The Black-Scholes model utilized the following inputs to value the options granted during the three months ended December 31, 2020:

 

Fair value assumptions – Options:   December 31, 2020
Risk free interest rate     0.18-0.22%
Expected term (years)     3
Expected volatility     167%-172%
Expected dividends     0%

 

As of December 31, 2020, the Company expects to recognize $1,040,030 of stock-based compensation for the non-vested outstanding options over a weighted-average period of 1.01 years.

 

Option activity for the three months ended December 31, 2019

 

During the three months ended December 31, 2019, the Company issued 136,697 options to purchase shares of common stock to employees, the shares were granted at quoted market prices ranging from $4.50 to $8.50. The options were valued at issuance using the Black Scholes model and stock compensation expense of $478,022 was recorded as a result of the issuances.

 

The Black-Scholes model utilized the following inputs to value the options granted during the three months ended December 31, 2019:

 

Fair value assumptions – Options:   December 31, 2019
Risk free interest rate     1.52-1.73%
Expected term (years)     3-5
Expected volatility     124%-144%
Expected dividends     0%